Terms: = Breast cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Prognosis
50 results:
1. The prognostic value of stem cell markers in triple-negative breast cancer.
Almási S; Nagy Á; Krenács T; Lantos T; Zombori T; Cserni G
Pathol Oncol Res; 2023; 29():1611365. PubMed ID: 38188613
[TBL] [Abstract] [Full Text] [Related]
2. Circular RNA_0000326 accelerates breast cancer development via modulation of the miR-9-3p/YAP1 axis.
Xue XL; Zhao S; Xu MC; Li Y; Liu WF; Qin HZ
Neoplasma; 2023 Jun; 70(3):430-442. PubMed ID: 37498061
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of the oct3/4 Network in Basal breast cancer Is Associated with Its Metastatic Potential and Shows Tissue Dependent Variability.
Rajan RG; Krutilina RI; Ignatova TN; Pavicevich ZS; Dulatova GM; Lane MA; Chatterjee AR; Rooney RJ; Antony M; Hagerty VR; Kukekov NV; Hanafy KA; Vrionis FD
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298091
[TBL] [Abstract] [Full Text] [Related]
4. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
5. Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces cancer Stem Cells in Triple Negative breast cancer.
Bano A; Stevens JH; Modi PS; Gustafsson JÅ; Strom AM
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982940
[TBL] [Abstract] [Full Text] [Related]
6. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC.
Marni R; Malla M; Chakraborty A; Malla R
Life Sci; 2023 May; 320():121534. PubMed ID: 36889667
[TBL] [Abstract] [Full Text] [Related]
7. Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.
Liu X; Ye Y; Zhu L; Xiao X; Zhou B; Gu Y; Si H; Liang H; Liu M; Li J; Jiang Q; Li J; Yu S; Ma R; Su S; Liao JY; Zhao Q
Nat Commun; 2023 Jan; 14(1):238. PubMed ID: 36646707
[TBL] [Abstract] [Full Text] [Related]
8. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway.
Liao Y; Luo Z; Liu Y; Xue W; He S; Chen X; Ren H; Yang X; Zhu D; Su Z; Huang Q; Guo H
J Ethnopharmacol; 2023 Apr; 305():116133. PubMed ID: 36603788
[TBL] [Abstract] [Full Text] [Related]
9. Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.
Sánchez-Botet A; Quandt E; Masip N; Escribá R; Novellasdemunt L; Gasa L; Li VSW; Raya Á; Clotet J; Ribeiro MPC
Cell Oncol (Dordr); 2021 Dec; 44(6):1273-1286. PubMed ID: 34604945
[TBL] [Abstract] [Full Text] [Related]
10. Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling.
Feng X; Cao A; Qin T; Zhang Q; Fan S; Wang B; Song B; Yu X; Li L
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34528694
[TBL] [Abstract] [Full Text] [Related]
11. The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS).
Al-Kawaz A; Ali R; Toss MS; Miligy IM; Mohammed OJ; Green AR; Madhusudan S; Rakha EA
Breast Cancer Res Treat; 2021 Nov; 190(1):39-51. PubMed ID: 34406589
[TBL] [Abstract] [Full Text] [Related]
12.
Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
[TBL] [Abstract] [Full Text] [Related]
13. FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner.
Sun HL; Men JR; Liu HY; Liu MY; Zhang HS
Arch Biochem Biophys; 2020 May; 685():108349. PubMed ID: 32209309
[TBL] [Abstract] [Full Text] [Related]
14. Stratification Using hTERT and Stem Cell Markers Confers a Good prognosis in Invasive breast cancer.
Wazir U; Tayeh S; Orakzai MAW; Martin TA; Jiang WG; Mokbel K
Cancer Genomics Proteomics; 2020; 17(2):169-174. PubMed ID: 32108039
[TBL] [Abstract] [Full Text] [Related]
15. TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling.
Zhu R; Gires O; Zhu L; Liu J; Li J; Yang H; Ju G; Huang J; Ge W; Chen Y; Lu Z; Wang H
Nat Commun; 2019 Jun; 10(1):2863. PubMed ID: 31253779
[TBL] [Abstract] [Full Text] [Related]
16. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance.
Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression.
Tao W; Wang C; Zhu B; Zhang G; Pang D
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910842
[TBL] [Abstract] [Full Text] [Related]
18. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human breast cancer Cells through Up-Regulation of IFIT2.
Koh SY; Moon JY; Unno T; Cho SK
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875792
[TBL] [Abstract] [Full Text] [Related]
19. Long non‑coding RNA FOXD2‑AS1/miR‑150‑5p/PFN2 axis regulates breast cancer malignancy and tumorigenesis.
Jiang M; Qiu N; Xia H; Liang H; Li H; Ao X
Int J Oncol; 2019 Mar; 54(3):1043-1052. PubMed ID: 30628646
[TBL] [Abstract] [Full Text] [Related]
20. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
[TBL] [Abstract] [Full Text] [Related]
[Next]
